コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eased sensitivity to inactivation by PMSF of butyrylcholinesterase.
2 sembly of all detectable asymmetric AChE and butyrylcholinesterase.
3 cked asymmetric forms of the AChE homologue, butyrylcholinesterase.
4 serum acetylcholinesterase and equine serum butyrylcholinesterase.
5 replaced by aliphatic amino acid residues in butyrylcholinesterase.
6 expression network immediately downstream of butyrylcholinesterase.
7 se, alpha-amylase, acetylcholinesterase, and butyrylcholinesterase.
8 with human albumin, free tyrosine, and human butyrylcholinesterase.
9 mammalian CEs, as well as human acetyl- and butyrylcholinesterase.
10 ctivity toward human acetylcholinesterase or butyrylcholinesterase.
11 n inhibitor of human acetylcholinesterase or butyrylcholinesterase.
13 etylcholinesterase [(-)9] and of acetyl- and butyrylcholinesterase (AChE and BChE) [(-)10], respectiv
16 agent that inhibits acetylcholinesterase and butyrylcholinesterase activities, to inhibit cholinester
19 expression system using genes encoding human butyrylcholinesterase and a proline-rich peptide under e
20 ists in cabin air may form adducts on plasma butyrylcholinesterase and albumin, detectable by mass sp
21 eins is either limited (e.g., plasma-derived butyrylcholinesterase and erythrocytic acetylcholinester
22 on DNA dendrimer scaffolds that incorporate butyrylcholinesterase and fluorescein in a nanoscale arr
24 re to combinations of chemicals that inhibit butyrylcholinesterase and neuropathy target esterase.
25 ed one major oligosaccharide for human serum butyrylcholinesterase and three or four major oligosacch
26 ives with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as wel
27 (alpha-glucosidase, acetylcholinesterase and butyrylcholinesterase) and free radicals (DPPH, nitric o
29 tivities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Abeta42 and tau
30 rum butyrylcholinesterase, recombinant human butyrylcholinesterase, and recombinant mouse acetylcholi
31 controls inhibited acetylcholinesterase and butyrylcholinesterase, and this effect was increased in
33 inesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophos
34 s Arg residues in neuroligin-3 (Arg-451), in butyrylcholinesterase (Arg-386), and in acetylcholineste
35 ith a gene transfer paradigm using a related butyrylcholinesterase-based cocaine hydrolase (CocH).
37 developed for simultaneously measuring both butyrylcholinesterase (BChE) activity and the total amou
40 njugates toward acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and structurally close to t
41 hly potent and selective inhibitors of human butyrylcholinesterase (BChE) and will test the novel hyp
42 rdose, we undertook molecular engineering of butyrylcholinesterase (BChE) as a cocaine hydrolase so t
43 alization of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at the NMJ to bring out the
44 lectrochemical measurements, in parallel, of butyrylcholinesterase (BChE) enzyme activity towards but
45 the demonstration of Abeta immunoreactivity, butyrylcholinesterase (BChE) enzyme activity, and thiofl
48 f aprophen but also preferentially inhibited butyrylcholinesterase (BChE) in contrast to acetylcholin
59 ocaine abuse based on viral gene transfer of butyrylcholinesterase (BChE) mutated for accelerated coc
60 hes brain reward centers using mutated human butyrylcholinesterase (BChE) or cocaine hydrolase (CocH)
61 a dried spot activity assay for quantifying butyrylcholinesterase (BChE) specific activity which is
64 o, and reactivation rates for OP-inactivated butyrylcholinesterase (BChE) were greater than those for
65 e inactivation of recombinant (r) human (Hu) butyrylcholinesterase (BChE) with P(S)C(S)- and P(S)C(R)
66 otent inhibitors of either acetyl- (AChE) or butyrylcholinesterase (BChE) with specific compounds exh
67 m-based inhibitors were bound to pure equine butyrylcholinesterase (BChE), a 364 kDa homotetramer, an
68 all molecule and drug metabolism, especially butyrylcholinesterase (BCHE), a gene involved in the met
70 nhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), and tyrosinase (TYRO) by m
71 acetylthiocholine (ATC) by the hydrolysis of butyrylcholinesterase (BChE), could cause the aggregatio
72 rat contain acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), enzymes implicated in neur
73 nhibit human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), ex vivo, demonstrated that
74 sfer of the acyl-ghrelin hydrolyzing enzyme, butyrylcholinesterase (BChE), in a mouse model of diet-i
76 lacing a His near the oxyanion hole of human butyrylcholinesterase (BChE), we made an esterase (G117H
78 rate-determining transition state for human butyrylcholinesterase (BChE)-catalyzed hydrolysis of (-)
79 molecular mechanical (QM/MM) calculations on butyrylcholinesterase (BChE)-catalyzed hydrolysis of (-)
80 uncover the fundamental reaction pathway for butyrylcholinesterase (BChE)-catalyzed hydrolysis of ghr
92 c frequency of the gene for the K variant of butyrylcholinesterase (BCHE-K) was 0.17 in 74 subjects w
93 of all, these compounds selectively inhibit butyrylcholinesterase, block NMDA receptors containing N
95 olinesterase inhibitor therapy should target butyrylcholinesterase (BuChE) in Alzheimer's disease (AD
96 potential as acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors was also assess
97 ested compounds inhibited the related enzyme butyrylcholinesterase (BuChE) up to their aqueous solubi
98 e esterases, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), and several of their natu
103 serum acetylcholinesterase, and equine serum butyrylcholinesterase) clearly demonstrated a reduced he
104 action of these compounds with their target, butyrylcholinesterase, depends on the stereochemistry ar
105 olog (yeast, alpha-1,2-glucosyltransferase); butyrylcholinesterase; dipeptidyl-peptidase 4 (CD26, ade
108 ganophosphorus toxicants (OP) for mutants of butyrylcholinesterase (EC 3.1.1.8; BChE) and acetylcholi
109 xpression quantitative trait locus for BCHE (butyrylcholinesterase), expressed in thalamus tissue.
110 forms of plasma cholinesterases (human serum butyrylcholinesterase, fetal bovine serum acetylcholines
112 ngle locus immediately adjacent to the BCHE (butyrylcholinesterase) gene associated with plasma aspir
113 H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more p
114 nesterase is found to decline in AD, whereas butyrylcholinesterase has been found to either increase
116 t into three efficient reactivators of human butyrylcholinesterase (hBChE) inhibited covalently by ne
120 astigmine resulted in complete inhibition of butyrylcholinesterase in all structures at 10(-5) M.
122 Dosing with CPF yielded an inhibition of 35% butyrylcholinesterase in plasma and 45% acetylcholineste
123 inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Abe
125 inhibitor BW284C51 and more potent than the butyrylcholinesterase inhibitors iso-OMPA and ethopropaz
126 esterase, which is replaced by A328 in human butyrylcholinesterase, is implicated in the binding of l
127 itory activity against acetylcholinesterase, butyrylcholinesterase, lipoxygenase, and tyrosinase; the
129 ld-type T. californica AChE, wild-type mouse butyrylcholinesterase, mouse Y330F, Y330A, F288L, and F2
130 MDE-FACS allowed the identification of human butyrylcholinesterase mutants that undergo self-reactiva
131 Inhibition studies of ethopropazine with butyrylcholinesterase mutants, where A328 (KI = 0.18 mic
132 bition studies of (-)-huperzine A with human butyrylcholinesterase mutants, where A328 (KI = 194.6 mi
134 galactose residues on tetrameric human serum butyrylcholinesterase, recombinant human butyrylcholines
135 (-14)) and on chromosome 3 upstream of BCHE (butyrylcholinesterase) (rs509208, P=2.7 x 10(-8)) in a r
136 nt in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Abeta aggregation, a
137 ocholine, while remaining insensitive to the butyrylcholinesterase-specific inhibitor iso-OMPA and di
138 stration of a quadruple mutant albumin-fused butyrylcholinesterase that efficiently catalyzes hydroly
139 identify a unique form of recombinant human butyrylcholinesterase that mimics the native enzyme asse
140 serum acetylcholinesterase, and equine serum butyrylcholinesterase, this ratio was approximately 0.5.
141 identical Cys substitution was reported for butyrylcholinesterase through genotyping patients with p
142 ding potency toward acetylcholinesterase and butyrylcholinesterase using enzyme kinetic analysis.
146 caine hydrolase (CocE) engineered from human butyrylcholinesterase will transiently accelerate cocain
147 17 with His to make the G117H mutant endowed butyrylcholinesterase with the ability to catalyze the h
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。